Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)

China · Delayed Price · Currency is CNY

70.20

-0.70 (-0.99%)

Jun 9, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2016	FY 2015
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Molecular Building Blocks, Tool Compounds and Biochemical Reagents	1.99B	-	-				235.68M	150.64M
Molecular Building Blocks, Tool Compounds and Biochemical Reagents Growth	-	-	-				56.46%	-
Active Pharmaceutical Ingredient, Intermediate and Preparations	872.24M	-	-				167.25M	148.19M
Active Pharmaceutical Ingredient, Intermediate and Preparations Growth	-	-	-				12.86%	-
Total	2.86B	-	-				402.93M	298.83M
Total Growth	-	-	-				34.84%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2016	FY 2015
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	1.71B	-	-				235.89M	175.11M
China Growth	-	-	-				34.72%	-
Overseas	1.16B	-	-				167.04M	123.73M
Overseas Growth	-	-	-				35.01%	-
Total	2.86B	-	-				402.93M	298.83M
Total Growth	-	-	-				34.84%	-

Source: S&P Global Market Intelligence.